Evidence map›Paper›PMID 22868232›Full record

ArticleInternational journal of pharmaceutics2012

Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

Tina Kauss, Karen Gaudin, Alexandra Gaubert, Boubakar Ba, Serena Tagliaferri, Fawaz Fawaz, Jean-Louis Fabre, Jean-Michel Boiron, Xavier Lafarge, Nicholas J White and 2 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of pharmaceutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Dosage uniformity problems which occur due to technological errors in extemporaneously prepared suppositories in hospitals and pharmacies.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2014
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Tina KaussUniv. Bordeaux, EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Bordeaux, France. tina.kauss@u-bordeaux2.fr
Karen Gaudin
Alexandra Gaubert
Boubakar Ba
Serena Tagliaferri
Fawaz Fawaz
Jean-Louis Fabre
Jean-Michel Boiron
Xavier Lafarge
Nicholas J White
Piero L Olliaro
Pascal Millet
Université de Bordeaux · FRÉtablissement Français du Sang · FRNuffield Orthopaedic Centre · GBInternational Office for Water · FR

Funding

Wellcome Trust 085242/Z/08/ZWellcome Trust 089275Wellcome Trust 093956
6 · The paper itself

Abstract

The aim of this study was to identify a candidate formulation for further development of a home or near-home administrable paediatric rectal form of a broad-spectrum antibiotic - specially intended for (emergency) use in tropical rural settings, in particular for children who cannot take medications orally and far from health facilities where injectable treatments can be given. Azithromycin, a broad-spectrum macrolide used orally or intravenously for the treatment of respiratory tract, skin and soft tissue infections, was selected because of its pharmacokinetic and therapeutic properties. Azithromycin in vitro solubility and stability in physiologically relevant conditions were studied. Various pharmaceutical forms, i.e. rectal suspension, two different rectal gels, polyethylene glycol (PEG) suppository and hard gelatin capsule (HGC) were assessed for in vitro dissolution and in vivo bioavailability in the rabbit. Azithromycin PEG suppository appears to be a promising candidate.

Indexed as

AcrylatesAdministration, RectalAnimalsAnti-Bacterial AgentsAzithromycinGelatinHydrogelsHydrogen-Ion ConcentrationHypromellose DerivativesMethylcellulosePolyethylene GlycolsRabbitsAcrylatesAnti-Bacterial AgentsAzithromycincarbopol 974P NFGelatinHydrogelsHypromellose DerivativesMethylcellulosePolyethylene Glycols

Identifiers

PMID22868232
PMCPMC3464429
OpenAlexW2027174664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.